Physitrack PLC reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was EUR 3.85 million compared to EUR 3.37 million a year ago. Net loss was EUR 0.24016 million compared to net income of EUR 0.016658 million a year ago. Basic loss per share from continuing operations was EUR 0.01. Diluted loss per share from continuing operations was EUR 0.01.
For the nine months, sales was EUR 11.34 million compared to EUR 8.99 million a year ago. Net loss was EUR 0.557452 million compared to EUR 0.550063 million a year ago. Basic loss per share from continuing operations was EUR 0.03 compared to EUR 0.03 a year ago. Diluted loss per share from continuing operations was EUR 0.03 compared to EUR 0.03 a year ago.